Article info

Download PDFPDF

Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era

Authors

  1. Correspondence to Dr Louise Downey; Louise.downey{at}hey.nhs.uk
View Full Text

Citation

Downey L, Acharya N, Devonport H, et al
Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era

Publication history

  • Received December 22, 2020
  • Revised February 3, 2021
  • Accepted February 11, 2021
  • First published April 27, 2021.
Online issue publication 
April 27, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.